1. Home
  2. FAMI vs ALZN Comparison

FAMI vs ALZN Comparison

Compare FAMI & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Farmmi Inc.

FAMI

Farmmi Inc.

HOLD

Current Price

$1.48

Market Cap

8.7M

ML Signal

HOLD

Logo Alzamend Neuro Inc.

ALZN

Alzamend Neuro Inc.

HOLD

Current Price

$2.22

Market Cap

9.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FAMI
ALZN
Founded
2015
2016
Country
China
United States
Employees
N/A
N/A
Industry
Packaged Foods
Medicinal Chemicals and Botanical Products
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.7M
9.0M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
FAMI
ALZN
Price
$1.48
$2.22
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$42.00
AVG Volume (30 Days)
5.8K
97.4K
Earning Date
01-26-2026
12-09-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$43,831,754.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.26
$1.88
52 Week High
$7.07
$12.06

Technical Indicators

Market Signals
Indicator
FAMI
ALZN
Relative Strength Index (RSI) 44.81 49.18
Support Level $1.45 $2.03
Resistance Level $1.54 $2.31
Average True Range (ATR) 0.10 0.16
MACD 0.01 0.02
Stochastic Oscillator 65.09 72.34

Price Performance

Historical Comparison
FAMI
ALZN

About FAMI Farmmi Inc.

Farmmi Inc is an investment holding company. Through its subsidiaries, it acts as a supplier of agricultural products. It is an agricultural technology enterprise focused on its supply chain platform by promoting edible mushroom products and agriculture technology. Its product offerings include tapioca, corn, red dates, shiitake mushrooms, mu er fungus, other edible fungi, and other agricultural products. Geographically, the company's products are sold in China, Southeast Asia, Japan, North America, Europe, and the Middle East under the Forasen and Farmmi brands.

About ALZN Alzamend Neuro Inc.

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.

Share on Social Networks: